# ARS Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:29100043-d006-4164-b99a-e78fd7d5dfab | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ars-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-21T04:46:27.582182+00:00 | | Last reviewed | 2026-10-21T04:46:27.582182+00:00 | ## Identity - Legal name: ARS Pharmaceuticals, Inc. - Display name: ARS Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-21T10:39:19.025676+00:00 | | Completeness | 0.409 | | Record Quality | 0.846 | | Directors | 9 | | Committees | 1 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brenton L. Saunders: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:7 - Laura Shawver: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:8 - Michael Kelly: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:9 - Peter A Thompson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:10 - Peter Kolchinsky: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. Committees: Nominating Committee (chair). claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:11 - Phillip Schneider: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. Committees: Nominating Committee (member). claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:12 - Pratik Shah: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:13 - Rajeev Dadoo: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:14 - Saqib Islam: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-29. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:15 ## Committees - Nominating Committee (nominating_governance). Chair: Peter Kolchinsky. Members: Peter Kolchinsky (chair, current); Phillip Schneider (member, current). committee_id=alpha:committee:ars-pharmaceuticals-inc:nominating-committee ## Executive leadership - Alexander A. Fitzpatrick: Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:16 - Brian Dorsey: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:17 - Eric Karas: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:18 - Justin Chakma: Chief Business Officer. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:19 - Kathleen D. Scott: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:20 - Richard Lowenthal: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:21 - Sarina Tanimoto: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:22 ## Governance events - DIRECTOR_APPOINTED: Laura Shawver seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:10yp0cs1t0u5ou - DIRECTOR_APPOINTED: Peter A Thompson seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:86y5mh7w9g3r - DIRECTOR_APPOINTED: Peter Kolchinsky seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:7a5fro8jzm0m - DIRECTOR_APPOINTED: Pratik Shah seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:yg2ht41lmz6e8 - DIRECTOR_APPOINTED: Rajeev Dadoo seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:18b7mzp1z9gu3 - DIRECTOR_APPOINTED: Saqib Islam seat on ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:82ehg213f3ew6 - GC_CHANGED: Alexander A. Fitzpatrick executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:gwowtrw3xc7t - EXECUTIVE_APPOINTED: Brian Dorsey executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:1l6u9qe1w5ujio - EXECUTIVE_APPOINTED: Eric Karas executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:10gg3n99y5uf - EXECUTIVE_APPOINTED: Justin Chakma executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:108e7ui1ty569u - CFO_CHANGED: Kathleen D. Scott executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:x53fwsrhdnsw - CEO_CHANGED: Richard Lowenthal executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:sqmrkh70n5ah - EXECUTIVE_APPOINTED: Sarina Tanimoto executive of ARS Pharmaceuticals, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:xxjnaij1hjnu - DIRECTOR_APPOINTED: Brenton L. Saunders seat on ARS Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:1ce9b9j1vbx6fl - DIRECTOR_APPOINTED: Michael Kelly seat on ARS Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:qpod48v66hyg - DIRECTOR_APPOINTED: Phillip Schneider seat on ARS Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-21T04:46:27.582182+00:00. event_id=alpha:event:transition:2j9ukc1o59xd2 ## Scoped resources - `alpha://company/ars-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record - `alpha://company/ars-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/ars-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/ars-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=board - `alpha://company/ars-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/ars-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/ars-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/ars-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/ars-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/ars-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/ars-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/ars-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/ars-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/ars-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/ars-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/ars-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/ars-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/ars-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/ars-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/ars-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=events - `alpha://company/ars-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/ars-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/ars-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:peter-kolchinsky-spry","name":"Peter Kolchinsky"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:phillip-schneider-spry","name":"Phillip Schneider"},"source_id":"governance_people_committees"}` ## Leadership - Brenton L. Saunders: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:7. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Laura Shawver: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:8. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Michael Kelly: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Peter A Thompson: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:10. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Peter Kolchinsky: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:11. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Phillip Schneider: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:12. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Pratik Shah: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:13. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Rajeev Dadoo: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:14. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Saqib Islam: Director. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:15. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Alexander A. Fitzpatrick: Chief Legal Officer and Secretary. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:16. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Brian Dorsey: Chief Operating Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:17. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Eric Karas: Chief Commercial Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:18. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Justin Chakma: Chief Business Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:19. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Kathleen D. Scott: Chief Financial Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:20. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Richard Lowenthal: President and Chief Executive Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:21. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. - Sarina Tanimoto: Chief Medical Officer. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:leadership_role:22. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Nominating Committee: Chair Peter Kolchinsky; Members Peter Kolchinsky (Chair); Phillip Schneider. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:19b8931e5a0ccb37f37e0e5fb7d90d5fff2f69990d16624012e344ed24bb0bc9. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ARS Pharmaceuticals, Inc.. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. ## Entity Status - Public listing published. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. ## Published Fact - US. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. - Healthcare. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. - Biotechnology. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. ## Committee Appointment - Peter Kolchinsky: chair, Nominating Committee. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:19b8931e5a0ccb37f37e0e5fb7d90d5fff2f69990d16624012e344ed24bb0bc9. - Phillip Schneider: member, Nominating Committee. Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:19b8931e5a0ccb37f37e0e5fb7d90d5fff2f69990d16624012e344ed24bb0bc9. ## Security Listing - SPRY (NASDAQ). Claim: alpha:claim:company:29100043-d006-4164-b99a-e78fd7d5dfab:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:f02f34abc4764299bd2e2cc37965fc5cdd3b578419cde17cc7d23984ac6070ad: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ars-pharmaceuticals-inc). - alpha:projection-evidence:document:62f1b3b00ba70303cdbeb7da840f31cfa3bf8f09a78a626e17e0936182dd9bf2: [DEF 14A spry-20260429.htm](https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm). - alpha:projection-evidence:19b8931e5a0ccb37f37e0e5fb7d90d5fff2f69990d16624012e344ed24bb0bc9: [Nominating Committee](https://www.sec.gov/Archives/edgar/data/1671858/000119312526191433/spry-20260429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ars-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/ars-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ars-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/ars-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-21T10:39:18.789515+00:00; recorded 2026-10-21T10:39:18.789515+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.